Trial Profile
PHASE II TRIAL OF THE SEQUENTIAL ADMINISTRATION OF COMBINATIONS OF GEMCITABINE-CISPLATIN AND CARBOPLATIN-PACLITAXEL FOR THE TREATMENT OF PATIENTS WITH ADVANCED CARCINOMA OF THE OVARY WITH SUB-OPTIMAL CYTOREDUCTION.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2011
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Carboplatin; Cisplatin; Paclitaxel
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 27 Jul 2011 New trial record